Published Date：Jan. 2021
Industry：
Pages：116 Table Number：132
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Dry Eye Syndrome Treatment market in this environment. In terms of revenue, this research report indicated that the global Dry Eye Syndrome Treatment market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Dry Eye Syndrome Treatment industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Allergan Plc. aims at producing XX Dry Eye Syndrome Treatment in 2020, with XX % production to take place in global market, Novartis AG accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Dry Eye Syndrome Treatment Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Dry Eye Syndrome Treatment Market? Allergan Plc. Novartis AG Bausch Health Companies Johnson and Johnson Vision Care I-Med Pharma Santen Pharmaceuticals Co. Ltd. AFT Pharmaceuticals Novaliq GmBH Otsuka Pharmaceutical Co. Ltd. Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. ... Major Type of Dry Eye Syndrome Treatment Covered in XYZResearch report: Cyclosporine Oral Corticosteroid Artificial Tears Omega Supplements Punctual Bags Others Application Segments Covered in XYZResearch Market Hospital Pharmacies Retail Pharmacies Supermarket/ Hypermarket Other Stores Online Pharmacies For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Dry Eye Syndrome Treatment Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Cyclosporine -Product Introduction and Major Manufacturers 1.1.2 Oral Corticosteroid -Product Introduction and Major Manufacturers 1.1.3 Artificial Tears -Product Introduction and Major Manufacturers 1.1.4 Omega Supplements -Product Introduction and Major Manufacturers 1.1.5 Punctual Bags -Product Introduction and Major Manufacturers 1.1.6 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Dry Eye Syndrome Treatment Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Dry Eye Syndrome Treatment Market 3.1.1 Top Companies leading Dry Eye Syndrome Treatment Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Dry Eye Syndrome Treatment Market 3.2.1 Top Companies leading Dry Eye Syndrome Treatment Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Dry Eye Syndrome Treatment Market 3.3.1 Top Companies leading Dry Eye Syndrome Treatment Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Dry Eye Syndrome Treatment Market 3.4.1 Top Companies leading Dry Eye Syndrome Treatment Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Dry Eye Syndrome Treatment Market 3.5.1 Top Companies leading Dry Eye Syndrome Treatment Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Dry Eye Syndrome Treatment Market 3.6.1 Top Companies leading Dry Eye Syndrome Treatment Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Dry Eye Syndrome Treatment Market 3.7.1 Top Companies leading Dry Eye Syndrome Treatment Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Dry Eye Syndrome Treatment Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Dry Eye Syndrome Treatment Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2026) 5.2 Global Dry Eye Syndrome Treatment Sales Value and Growth Rate (2021-2026) 6 Dry Eye Syndrome Treatment Competitive Analysis 6.1 Allergan Plc. 6.1.1 Allergan Plc. Company Profiles 6.1.2 Allergan Plc. Product Introduction 6.1.3 Allergan Plc. Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Novartis AG 6.2.1 Novartis AG Company Profiles 6.2.2 Novartis AG Product Introduction 6.2.3 Novartis AG Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Bausch Health Companies 6.3.1 Bausch Health Companies Company Profiles 6.3.2 Bausch Health Companies Product Introduction 6.3.3 Bausch Health Companies Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Johnson and Johnson Vision Care 6.4.1 Johnson and Johnson Vision Care Company Profiles 6.4.2 Johnson and Johnson Vision Care Product Introduction 6.4.3 Johnson and Johnson Vision Care Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 I-Med Pharma 6.5.1 I-Med Pharma Company Profiles 6.5.2 I-Med Pharma Product Introduction 6.5.3 I-Med Pharma Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Santen Pharmaceuticals Co. Ltd. 6.6.1 Santen Pharmaceuticals Co. Ltd. Company Profiles 6.6.2 Santen Pharmaceuticals Co. Ltd. Product Introduction 6.6.3 Santen Pharmaceuticals Co. Ltd. Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 AFT Pharmaceuticals 6.7.1 AFT Pharmaceuticals Company Profiles 6.7.2 AFT Pharmaceuticals Product Introduction 6.7.3 AFT Pharmaceuticals Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Novaliq GmBH 6.8.1 Novaliq GmBH Company Profiles 6.8.2 Novaliq GmBH Product Introduction 6.8.3 Novaliq GmBH Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Otsuka Pharmaceutical Co. Ltd. 6.9.1 Otsuka Pharmaceutical Co. Ltd. Company Profiles 6.9.2 Otsuka Pharmaceutical Co. Ltd. Product Introduction 6.9.3 Otsuka Pharmaceutical Co. Ltd. Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Sun Pharmaceutical Industries Ltd. 6.10.1 Sun Pharmaceutical Industries Ltd. Company Profiles 6.10.2 Sun Pharmaceutical Industries Ltd. Product Introduction 6.10.3 Sun Pharmaceutical Industries Ltd. Dry Eye Syndrome Treatment Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 6.11 Teva Pharmaceutical Industries Ltd. 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Dry Eye Syndrome Treatment Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Dry Eye Syndrome Treatment Sales (K Unit) by Type (2015-2026) Figure Global Dry Eye Syndrome Treatment Sales (K Unit) and Growth Rate (2015-2026) Figure Global Dry Eye Syndrome Treatment Sales Market Share (%) by Type (2019 -2020) Table Global Dry Eye Syndrome Treatment Sales Value (Million USD) by Type (2015-2026) Figure Global Dry Eye Syndrome Treatment Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Dry Eye Syndrome Treatment Sales Value Market Share (%) by Type (2019-2020) Table Global Dry Eye Syndrome Treatment Sales (K Unit) by Application (2015-2026) Table China Dry Eye Syndrome Treatment Sales (K Unit) of Major Company (2015-2020) Table China Dry Eye Syndrome Treatment Sales Market Share of Major Company (2015-2020) Table China Dry Eye Syndrome Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure China Dry Eye Syndrome Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table China Dry Eye Syndrome Treatment Sales Value Share of Major Company (2015-2020) Table China Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) Table China Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Figure China Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Table EU Dry Eye Syndrome Treatment Sales (K Unit) of Major Company (2015-2020) Table EU Dry Eye Syndrome Treatment Sales Market Share of Major Company (2015-2020) Table EU Dry Eye Syndrome Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure EU Dry Eye Syndrome Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Dry Eye Syndrome Treatment Sales Value Share of Major Company (2015-2020) Table EU Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) Table EU Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Figure EU Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Table USA Dry Eye Syndrome Treatment Sales (K Unit) of Major Company (2015-2020) Table USA Dry Eye Syndrome Treatment Sales Market Share of Major Company (2015-2020) Table USA Dry Eye Syndrome Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure USA Dry Eye Syndrome Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Dry Eye Syndrome Treatment Sales Value Share of Major Company (2015-2020) Table USA Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) Table USA Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Figure USA Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Table Japan Dry Eye Syndrome Treatment Sales (K Unit) of Major Company (2015-2020) Table Japan Dry Eye Syndrome Treatment Sales Market Share of Major Company (2015-2020) Table Japan Dry Eye Syndrome Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Dry Eye Syndrome Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Dry Eye Syndrome Treatment Sales Value Share of Major Company (2015-2020) Table Japan Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) Table Japan Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Figure Japan Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Table India Dry Eye Syndrome Treatment Sales (K Unit) of Major Company (2015-2020) Table India Dry Eye Syndrome Treatment Sales Market Share of Major Company (2015-2020) Table India Dry Eye Syndrome Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure India Dry Eye Syndrome Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table India Dry Eye Syndrome Treatment Sales Value Share of Major Company (2015-2020) Table India Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) Table India Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Figure India Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Table Southeast Asia Dry Eye Syndrome Treatment Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Dry Eye Syndrome Treatment Sales Market Share of Major Company (2015-2020) Table Southeast Asia Dry Eye Syndrome Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Dry Eye Syndrome Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Dry Eye Syndrome Treatment Sales Value Share of Major Company (2015-2020) Table Southeast Asia Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Figure Southeast Asia Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Table South America Dry Eye Syndrome Treatment Sales (K Unit) of Major Company (2015-2020) Table South America Dry Eye Syndrome Treatment Sales Market Share of Major Company (2015-2020) Table South America Dry Eye Syndrome Treatment Sales Value (Million USD) of Major Company (2015-2020) Figure South America Dry Eye Syndrome Treatment Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Dry Eye Syndrome Treatment Sales Value Share of Major Company (2015-2020) Table South America Dry Eye Syndrome Treatment Price (USD/Unit), by Type (2019-2020) Table South America Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Figure South America Dry Eye Syndrome Treatment Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Dry Eye Syndrome Treatment Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Dry Eye Syndrome Treatment Figure Cost Structure of Dry Eye Syndrome Treatment in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Dry Eye Syndrome Treatment Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Dry Eye Syndrome Treatment Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Allergan Plc. Profiles Table Allergan Plc. Dry Eye Syndrome Treatment Product Introduction Table Allergan Plc. Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Allergan Plc. SWOT Analysis Table Novartis AG Profiles Table Novartis AG Dry Eye Syndrome Treatment Product Introduction Table Novartis AG Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Novartis AG SWOT Analysis Table Bausch Health Companies Profiles Table Bausch Health Companies Dry Eye Syndrome Treatment Product Introduction Table Bausch Health Companies Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Bausch Health Companies SWOT Analysis Table Johnson and Johnson Vision Care Profiles Table Johnson and Johnson Vision Care Dry Eye Syndrome Treatment Product Introduction Table Johnson and Johnson Vision Care Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Johnson and Johnson Vision Care SWOT Analysis Table I-Med Pharma Profiles Table I-Med Pharma Dry Eye Syndrome Treatment Product Introduction Table I-Med Pharma Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure I-Med Pharma SWOT Analysis Table Santen Pharmaceuticals Co. Ltd. Profiles Table Santen Pharmaceuticals Co. Ltd. Dry Eye Syndrome Treatment Product Introduction Table Santen Pharmaceuticals Co. Ltd. Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Santen Pharmaceuticals Co. Ltd. SWOT Analysis Table AFT Pharmaceuticals Profiles Table AFT Pharmaceuticals Dry Eye Syndrome Treatment Product Introduction Table AFT Pharmaceuticals Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure AFT Pharmaceuticals SWOT Analysis Table Novaliq GmBH Profiles Table Novaliq GmBH Dry Eye Syndrome Treatment Product Introduction Table Novaliq GmBH Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Novaliq GmBH SWOT Analysis Table Otsuka Pharmaceutical Co. Ltd. Profiles Table Otsuka Pharmaceutical Co. Ltd. Dry Eye Syndrome Treatment Product Introduction Table Otsuka Pharmaceutical Co. Ltd. Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Otsuka Pharmaceutical Co. Ltd. SWOT Analysis Table Sun Pharmaceutical Industries Ltd. Profiles Table Sun Pharmaceutical Industries Ltd. Dry Eye Syndrome Treatment Product Introduction Table Sun Pharmaceutical Industries Ltd. Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Sun Pharmaceutical Industries Ltd. SWOT Analysis Table Teva Pharmaceutical Industries Ltd. Profiles Table Teva Pharmaceutical Industries Ltd. Dry Eye Syndrome Treatment Product Introduction Table Teva Pharmaceutical Industries Ltd. Dry Eye Syndrome Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
